Infant Hyperglycemia
Symptoms, Doctors, Treatments, Advances & More

Learn About Infant Hyperglycemia

What is the definition of Infant Hyperglycemia?

Hyperglycemia is abnormally high blood sugar. The medical term for blood sugar is blood glucose.

This article discusses hyperglycemia in infants. Hyperglycemia can occur at any age.

What are the alternative names for Infant Hyperglycemia?

High blood sugar - infants; High blood glucose level - infants

What are the causes of Infant Hyperglycemia?

A healthy baby's body most often has very careful control of the blood sugar level by normal bodily systems. Insulin is the main hormone in the body that regulates blood sugar. Sick babies may have poor insulin function or low amounts. This causes poor control of the blood sugar and allows it to get high.

There can be specific causes of ineffective insulin function or a low insulin level. Causes may include infection, liver problems, hormone problems, and some medicines. Rarely, babies may actually have diabetes, and therefore have a low insulin level that results in high blood sugar.

What are the symptoms of Infant Hyperglycemia?

Babies with hyperglycemia often have no symptoms.

Sometimes, babies with a high blood sugar will produce large amounts of urine and may become dehydrated. High blood sugar may be a sign that the baby has added stress on the body due to problems such as an infection or heart failure.

Not sure about your diagnosis?
Check Your Symptoms
What is the outlook (prognosis) for Infant Hyperglycemia?

There are most often no long-term effects from a temporary high blood sugar level unless the baby has diabetes.

Who are the top Infant Hyperglycemia Local Doctors?
Luke Y. Ouyang
Distinguished in Infant Hyperglycemia
Internal Medicine
Distinguished in Infant Hyperglycemia
Internal Medicine

Texas Health Executive Direct

Allen, TX 
Languages Spoken:
English, Mandarin, Spanish

Luke Ouyang is a primary care provider, practicing in Internal Medicine in Allen, Texas. Dr. Ouyang is rated as a Distinguished provider by MediFind in the treatment of Infant Hyperglycemia. His top areas of expertise are Infant Hyperglycemia, Cirrhosis, Familial Combined Hyperlipidemia, and Xanthoma.

Amy L. Proffitt
Distinguished in Infant Hyperglycemia
Internal Medicine
Distinguished in Infant Hyperglycemia
Internal Medicine

FirstChoice Internal Medicine

301 Med Tech Pkwy, Ste 280, 
Johnson City, TN 
Languages Spoken:
English
Offers Telehealth

. Dr. Proffitt is rated as a Distinguished provider by MediFind in the treatment of Infant Hyperglycemia. Her top areas of expertise are Infant Hyperglycemia, Sitosterolemia, Vitamin B12 Deficiency Anemia, and Multiple Carboxylase Deficiency.

 
 
 
 
Learn about our expert tiers
Learn More
Paul B. Anthony
Distinguished in Infant Hyperglycemia
Internal Medicine | Geriatrics
Distinguished in Infant Hyperglycemia
Internal Medicine | Geriatrics

Texas Health Adult Care

2100 Hedgcoxe Road, Suite 100, 
Plano, TX 
Languages Spoken:
English

Paul Anthony is a primary care provider, practicing in Internal Medicine and Geriatrics in Plano, Texas. Dr. Anthony is rated as a Distinguished provider by MediFind in the treatment of Infant Hyperglycemia. His top areas of expertise are High Cholesterol, Infant Hyperglycemia, Sitosterolemia, and Vitamin B12 Deficiency Anemia.

What are the latest Infant Hyperglycemia Clinical Trials?
Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)

Summary: The purpose of this study is to confirm hypothesis that Glibenclamide can be administered orally and is an alternative to insulin therapy in treating transient hyperglycemia of premature newborns.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Exploring B-Type Natriuretic Peptide (BNP) Evolution, From the Neonatal to Adolescent Period, as a Tool to Early Identify the Risk for Metabolic Syndrome (MetS) in a Former Preterm and Full Term Adolescent Population

Summary: MetS is a syndrome characterized by a combination of diabetes, hypertension and visceral obesity, altered blood lipids, beginning in childhood, leading to chronic disease in adulthood. Adult criteria for defining MetS require a minimum of 3 risk factors, listed in the NCEP ATP III (National Cholesterol Education Program, Adult Treatment Panel III, ATP III), they are hyperglycaemia, hypertriglyceri...

Who are the sources who wrote this article ?

Published Date: October 07, 2025
Published By: Neil K. Kaneshiro, MD, MHA, Clinical Professor of Pediatrics, University of Washington School of Medicine, Seattle, WA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Escobar O, Gurtunca N, Viswanathan P, Witchel SF. Pediatric endocrinology. In: Zitelli, BJ, McIntire SC, Nowalk AJ, Garrison J, eds. Zitelli and Davis' Atlas of Pediatric Physical Diagnosis. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 9.

Garg M, Devaskar SU. Disorders of carbohydrate metabolism in the neonate. In: Martin RJ, Fanaroff AA, eds. Fanaroff and Martin's Neonatal-Perinatal Medicine. 12th ed. Philadelphia, PA: Elsevier; 2025:chap 90.

Kliegman RM, St. Geme JW, Blum NJ, et al. Diabetes mellitus. In: Kliegman RM, St. Geme JW, Blum NJ, et al, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2025:chap 629.